Protagenic Therapeutics, Inc.new (PTIX) Change in Accrued Expenses (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) posted Change in Accrued Expenses of $11,242 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$97,846 a year earlier.
Protagenic Therapeutics, Inc.new (PTIX) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Protagenic Therapeutics, Inc.new was -$139,287; for FY2026 (ended Mar 31, 2026), it was $17,421, down 91.5% from FY2025.
- Annual Change in Accrued Expenses shows a five-year compound annual growth rate of -44.8% (FY2021 to FY2026).
- In prior fiscal years, Protagenic Therapeutics, Inc.new's Change in Accrued Expenses was $206,039 in FY2025, $463,127 in FY2024, -$183,832 in FY2023 and -$91,596 in FY2022.
- Quarterly Change in Accrued Expenses has run from a low of -$155,028 in fiscal Q3 2026 to a high of $256,758 in fiscal Q1 2026 over five years.
- According to Business Quant data, Change in Accrued Expenses for the three prior fiscal quarters was -$9,038 (Q1 2027), $13,537 (Q4 2026) and -$155,028 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 11,242.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11,242.00 |
| Jun 30, 2026 | -9,038.00 |
| Mar 31, 2026 | 13,537.00 |
| Dec 31, 2025 | -155,028.00 |
| Sep 30, 2025 | -97,846.00 |
| Jun 30, 2025 | 256,758.00 |
| Mar 31, 2025 | 174,095.00 |
| Dec 31, 2024 | 218,595.00 |
| Sep 30, 2024 | 107,789.00 |
| Jun 30, 2024 | 345,900.00 |
| Mar 31, 2024 | -209,157.00 |
| Dec 31, 2023 | -304,674.00 |
| Sep 30, 2023 | -109,567.00 |
| Jun 30, 2023 | 123,197.00 |
| Mar 31, 2023 | 107,212.00 |
| Dec 31, 2022 | 145,557.00 |
| Sep 30, 2022 | 93,511.00 |
| Jun 30, 2022 | -319,095.00 |
| Mar 31, 2022 | -11,569.00 |
| Dec 31, 2021 | 102,052.00 |
Protagenic Therapeutics, Inc.new Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();